Follow
Daniel Kirby
Daniel Kirby
Lecturer in Pharmaceutics, Aston University
Verified email at aston.ac.uk
Title
Cited by
Cited by
Year
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens
Y Perrie, AR Mohammed, DJ Kirby, SE McNeil, VW Bramwell
International journal of pharmaceutics 364 (2), 272-280, 2008
4382008
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A …
J Davidsen, I Rosenkrands, D Christensen, A Vangala, D Kirby, Y Perrie, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1718 (1), 22-31, 2005
3822005
Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs
S Joshi, MT Hussain, CB Roces, G Anderluzzi, E Kastner, S Salmaso, ...
International journal of pharmaceutics 514 (1), 160-168, 2016
1482016
Liposome-based cationic adjuvant formulations (CAF): past, present, and future
D Christensen, EM Agger, LV Andreasen, D Kirby, P Andersen, Y Perrie
Journal of liposome research 19 (1), 2-11, 2009
1372009
The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs
MH Ali, B Moghaddam, DJ Kirby, AR Mohammed, Y Perrie
International journal of pharmaceutics 453 (1), 225-232, 2013
972013
A comparative study of cationic liposome and niosome‐based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and …
A Vangala, D Kirby, I Rosenkrands, EM Agger, P Andersen, Y Perrie
Journal of pharmacy and pharmacology 58 (6), 787-799, 2006
902006
PLGA microspheres for the delivery of a novel subunit TB vaccine
DJ Kirby, I Rosenkrands, EM Agger, P Andersen, AGA Coombes, Y Perrie
Journal of drug targeting 16 (4), 282-293, 2008
752008
The application of monolayer studies in the understanding of liposomal formulations
B Moghaddam, MH Ali, J Wilkhu, DJ Kirby, AR Mohammed, Q Zheng, ...
International journal of pharmaceutics 417 (1-2), 235-244, 2011
732011
The impact of ageing on the barriers to drug delivery
Y Perrie, RKS Badhan, DJ Kirby, D Lowry, AR Mohammed, D Ouyang
Journal of controlled release 161 (2), 389-398, 2012
722012
Pegylation of DDA: TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses
R Kaur, VW Bramwell, DJ Kirby, Y Perrie
Journal of controlled release 158 (1), 72-77, 2012
722012
Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent
MH Ali, DJ Kirby, AR Mohammed, Y Perrie
Journal of Pharmacy and Pharmacology 62 (11), 1646-1655, 2010
722010
Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability
N Miriyala, D Ouyang, Y Perrie, D Lowry, DJ Kirby
European Journal of Pharmaceutics and Biopharmaceutics 115, 197-205, 2017
682017
Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and …
R Kaur, VW Bramwell, DJ Kirby, Y Perrie
Journal of controlled release 164 (3), 331-337, 2012
572012
α, α′-trehalose 6, 6′-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying
D Christensen, D Kirby, C Foged, EM Agger, P Andersen, Y Perrie, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1778 (5), 1365-1373, 2008
512008
Formulation design considerations for oral vaccines
J Wilkhu, SE McNeil, DJ Kirby, Y Perrie
Therapeutic delivery 2 (9), 1141-1164, 2011
442011
Increased potential of a cationic liposome-based delivery system: enhancing stability and sustained immunological activity in pre-clinical development
AR Mohammed, VW Bramwell, DJ Kirby, SE McNeil, Y Perrie
European Journal of Pharmaceutics and Biopharmaceutics 76 (3), 404-412, 2010
432010
Recent developments in particulate-based vaccines
Y Perrie, D Kirby, VW Bramwell, AR Mohammed
Recent patents on drug delivery & formulation 1 (2), 117-129, 2007
372007
Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres
DJ Kirby, I Rosenkrands, EM Agger, P Andersen, AGA Coombes, Y Perrie
Journal of drug targeting 16 (7-8), 543-554, 2008
362008
Nonaqueous capillary zone electrophoresis of synthetic organic polypeptides
H Cottet, W Vayaboury, D Kirby, O Giani, J Taillades, F Schué
Analytical chemistry 75 (20), 5554-5560, 2003
352003
Noncovalent coatings for the separation of synthetic polypeptides by nonaqueous capillary electrophoresis
W Vayaboury, D Kirby, O Giani, H Cottet
Electrophoresis 26 (11), 2187-2197, 2005
272005
The system can't perform the operation now. Try again later.
Articles 1–20